{"Q": 1, "answer": "no", "rationale": "The segment describes uncertainty about manufacturing capacity, but does not use an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_14472", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment discusses vaccine manufacturing capacity factually, without high-potency language.", "method": "llm_batch", "batch_id": "batch_2_8168", "batch_size": 200, "batch_pos": 25, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "This describes future capability ('will be able to manufacture'), not realised impact.", "method": "llm_batch", "batch_id": "batch_3_15012", "batch_size": 200, "batch_pos": 171, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment contains no question.", "method": "llm_batch", "batch_id": "batch_4_16792", "batch_size": 200, "batch_pos": 155, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty about manufacturing capacity but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17848", "batch_size": 200, "batch_pos": 151, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15492", "batch_size": 200, "batch_pos": 106, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains 'too early to tell', which is a statement of uncertainty, not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_15604", "batch_size": 200, "batch_pos": 91, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes manufacturing capability ('will be able to manufacture').", "method": "llm_batch", "batch_id": "batch_8_16668", "batch_size": 200, "batch_pos": 123, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
